| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 6 |
| NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: A4HNI4
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 220 | 222 | PF00675 | 0.450 |
| CLV_PCSK_KEX2_1 | 213 | 215 | PF00082 | 0.412 |
| CLV_PCSK_PC1ET2_1 | 213 | 215 | PF00082 | 0.412 |
| CLV_PCSK_SKI1_1 | 214 | 218 | PF00082 | 0.355 |
| CLV_PCSK_SKI1_1 | 76 | 80 | PF00082 | 0.473 |
| DEG_APCC_DBOX_1 | 251 | 259 | PF00400 | 0.347 |
| DOC_MAPK_DCC_7 | 65 | 74 | PF00069 | 0.474 |
| DOC_MAPK_MEF2A_6 | 65 | 74 | PF00069 | 0.489 |
| DOC_USP7_MATH_1 | 146 | 150 | PF00917 | 0.618 |
| DOC_USP7_MATH_1 | 18 | 22 | PF00917 | 0.416 |
| DOC_USP7_MATH_1 | 70 | 74 | PF00917 | 0.637 |
| DOC_WW_Pin1_4 | 163 | 168 | PF00397 | 0.511 |
| LIG_14-3-3_CanoR_1 | 236 | 240 | PF00244 | 0.396 |
| LIG_Actin_WH2_2 | 127 | 145 | PF00022 | 0.471 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.450 |
| LIG_FHA_1 | 101 | 107 | PF00498 | 0.523 |
| LIG_FHA_2 | 1 | 7 | PF00498 | 0.586 |
| LIG_FHA_2 | 111 | 117 | PF00498 | 0.395 |
| LIG_FHA_2 | 17 | 23 | PF00498 | 0.412 |
| LIG_FHA_2 | 226 | 232 | PF00498 | 0.334 |
| LIG_HP1_1 | 70 | 74 | PF01393 | 0.466 |
| LIG_LIR_Gen_1 | 196 | 206 | PF02991 | 0.381 |
| LIG_LIR_Nem_3 | 196 | 201 | PF02991 | 0.378 |
| LIG_PTAP_UEV_1 | 147 | 152 | PF05743 | 0.474 |
| LIG_SH2_CRK | 198 | 202 | PF00017 | 0.374 |
| LIG_SH2_STAP1 | 180 | 184 | PF00017 | 0.468 |
| LIG_SH3_3 | 145 | 151 | PF00018 | 0.476 |
| LIG_SUMO_SIM_anti_2 | 190 | 196 | PF11976 | 0.410 |
| LIG_SUMO_SIM_par_1 | 70 | 75 | PF11976 | 0.462 |
| LIG_SxIP_EBH_1 | 9 | 20 | PF03271 | 0.409 |
| LIG_TRAF2_1 | 160 | 163 | PF00917 | 0.482 |
| MOD_CK1_1 | 118 | 124 | PF00069 | 0.382 |
| MOD_CK1_1 | 61 | 67 | PF00069 | 0.640 |
| MOD_CK2_1 | 110 | 116 | PF00069 | 0.398 |
| MOD_CK2_1 | 16 | 22 | PF00069 | 0.435 |
| MOD_GlcNHglycan | 135 | 138 | PF01048 | 0.503 |
| MOD_GlcNHglycan | 148 | 151 | PF01048 | 0.517 |
| MOD_GlcNHglycan | 30 | 33 | PF01048 | 0.422 |
| MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.636 |
| MOD_GSK3_1 | 106 | 113 | PF00069 | 0.401 |
| MOD_GSK3_1 | 163 | 170 | PF00069 | 0.459 |
| MOD_GSK3_1 | 8 | 15 | PF00069 | 0.482 |
| MOD_NEK2_1 | 12 | 17 | PF00069 | 0.551 |
| MOD_NEK2_1 | 133 | 138 | PF00069 | 0.530 |
| MOD_NEK2_1 | 141 | 146 | PF00069 | 0.584 |
| MOD_PKA_2 | 100 | 106 | PF00069 | 0.508 |
| MOD_PKA_2 | 235 | 241 | PF00069 | 0.398 |
| MOD_PKA_2 | 33 | 39 | PF00069 | 0.406 |
| MOD_Plk_1 | 118 | 124 | PF00069 | 0.479 |
| MOD_Plk_1 | 128 | 134 | PF00069 | 0.432 |
| MOD_Plk_1 | 180 | 186 | PF00069 | 0.443 |
| MOD_Plk_2-3 | 225 | 231 | PF00069 | 0.338 |
| MOD_Plk_4 | 33 | 39 | PF00069 | 0.418 |
| MOD_Plk_4 | 8 | 14 | PF00069 | 0.502 |
| MOD_ProDKin_1 | 163 | 169 | PF00069 | 0.502 |
| TRG_DiLeu_BaEn_1 | 129 | 134 | PF01217 | 0.354 |
| TRG_DiLeu_BaEn_1 | 22 | 27 | PF01217 | 0.392 |
| TRG_DiLeu_BaEn_1 | 240 | 245 | PF01217 | 0.391 |
| TRG_DiLeu_BaEn_1 | 49 | 54 | PF01217 | 0.557 |
| TRG_ENDOCYTIC_2 | 198 | 201 | PF00928 | 0.374 |
| TRG_ER_diArg_1 | 123 | 126 | PF00400 | 0.445 |
| TRG_ER_diArg_1 | 38 | 41 | PF00400 | 0.562 |
| TRG_Pf-PMV_PEXEL_1 | 24 | 28 | PF00026 | 0.396 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1HXE8 | Leptomonas seymouri | 45% | 79% |
| A0A3S7XA65 | Leishmania donovani | 62% | 82% |
| A4IC40 | Leishmania infantum | 62% | 82% |
| E9AFZ5 | Leishmania major | 60% | 100% |
| E9B748 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 63% | 82% |